"Designing Growth Strategies is in our DNA"

Diabetic Retinopathy Treatment Market Size, Share and Global Trend By Diabetic Retinopathy Type (Non-Proliferative Diabetic Retinopathy, Proliferative Diabetic Retinopathy), By Treatment Type (Anti-Vascular Endothelial Growth Factor (VEGF) Drug, Laser Surgery, Vitrectomy, Intraocular Steroid Injection), By End User (Hospitals, Ophthalmic Centres, Ambulatory Surgery Centres, Others) and Regional Forecast, 2024-2032

Region :Global | Report ID: FBI101153 | Status : Ongoing

 

KEY MARKET INSIGHTS

Diabetic retinopathy is a medical disorder, resulting from the complications of diabetes mellitus and is also one of the leading cause of blindness. Diabetic retinopathy is determined by the type of diabetes the individual is diagnosed with, amount of time that the individual has diabetes and the level to which the blood sugar is controlled. The symptoms of diabetic retinopathy include very mild to no symptoms at the beginning of the condition, blurred and fluctuating vision, impairment of color vision, eventually leading to blindness.

Management of diabetes is critical towards the prevention and successful treatment of diabetic retinopathy because excessive sugar in the blood can lead to the blocking of the tiny blood vessels nourishing the retina, cutting off the blood supply. This results in the formation of new blood vessels which are not perfectly developed, leading to being susceptible to leaks easily.

To gain extensive insights into the market, Request for Customization

Some of the associated complications of diabetic retinopathy include blindness, cataracts, vitreous hemorrhage, glaucoma, and retinal detachment. Diabetic retinopathy is highly treatable, even individuals diagnosed with advanced diabetic retinopathy have an estimated 95% chance of retaining their vision before the retina is permanently damaged.

The global diabetic retinopathy treatment market is anticipated to grow at faster CAGR, owing to a number of factors such as the increasing prevalence of diabetic retinopathy, increasing prevalence of diabetes of all types, and increasing incidence of associated complications such as blindness.

Moreover, increasing research advances in treatment and prevention and rising demand for preventive medical care through regular eye examinations is expected to boost the growth of the global diabetic retinopathy market during the forecast period. According to research conducted by the Centres for Disease Control and Preventions (CDC), in 2017, an estimated 4.2 million adults were suffering from diabetic retinopathy in the U.S.

Some of the factors limiting the growth of the global diabetic retinopathy treatment market are the negligence of people to the symptoms of diabetic retinopathy, poor management of treatment of diabetic retinopathy and increased risk of the associated side effects of the treatment options.

Key Players Covered


Some of the major companies that are present in the global diabetic retinopathy treatment market are F. Hoffmann-La Roche Ltd, Alimera Sciences, Abbott, Novartis AG, Regeneron Pharmaceuticals, Inc., Pfizer Inc., Bayer AG, and Oxurion NV, and others.

SEGMENTATION


























SEGMENTATION

 DETAILS

By Diabetic Retinopathy Type


· Non-Proliferative Diabetic Retinopathy

· Proliferative Diabetic Retinopathy 


By Treatment Type


· Anti-Vascular Endothelial Growth Factor (VEGF) Drug

· Laser Surgery

· Vitrectomy

· Intraocular Steroid Injection


By End User


· Hospitals

· Ophthalmic Centres

· Ambulatory Surgery Centres

· Others


By Geography


· North America (USA and Canada)

· Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)

· Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)

· Latin America (Brazil, Mexico and Rest of Latin America)

· Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)


 

Among the segmentation, anti-vascular endothelial growth factor (VEGF) drug in the treatment type segment is expected to hold a considerable share in the market during the forecast period. Proven significance in the treatment of diabetic retinopathy in clinical trials is expected to boost the adoption of anti-vascular endothelial growth factor (vegf) drug by 2026.

Key Insights 



  • The regulatory scenario for key countries

  • Pipeline Analysis

  • Epidemics of Diabetic Retinopathy – Key Countries

  • New Product Launches by Key Players

  • Recent industry developments such as partnerships, mergers, and acquisitions


Regional Analysis


North America is expected to account for the largest share in the global diabetic retinopathy market due to the increasing prevalence of diabetic retinopathy and associated complications, rise in the incidence of diabetes, and increasing demand for preventive care. Additionally, increasing awareness regarding regular eye examinations amongst populations, established healthcare systems, and access to advanced technologies is anticipated to boost the growth of the diabetic retinopathy treatment market in North America by 2026. The Asia Pacific expected to be is the fastest emerging market due to the rapidly increasing prevalence of diabetic retinopathy coupled with increasing disposable incomes and developing healthcare systems in emerging economies.

Key Industry Developments




  • In July 2018, Government of Australia announced funding provision for Nation Diabetes Eye Screening Program. The program is Australia’s first ever program to diagnose and treat people suffering from diabetic retinopathy across the Australia.
  • In April 2018, FDA approved first ever artificial intelligence based diagnostic system designed and developed by IDx Technologies Inc. The newly developed system enables to detect diabetic retinopathy amongst patients during regular clinic visits.
  • In April 2017, FDA approved Lucentis (ranibizumab injection) 0.3 mg, developed by Genentech, Inc., subsidiary of Roche group, for the treatment of diabetic retinopathy on monthly basis. It is the only FDA approved drug available for all types of diabetic retinopathy treatments.




  • Ongoing
  • 2023
  • 2019-2022
  • Pre Book
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase
Healthcare Clients
abbvie
Jubilant
Grifols
Lek
uniliver
Client Testimonials

“We are quite happy with the methodology you outlined. We really appreciate the time your team has spent on this project, and the efforts of your team to answer our questions.”

- One of the largest & renowned medical research centers based in the U.S. on a report on the U.S. NIPT Market.

“Thanks a million. The report looks great!”

- Feedback from a consultant on a report on the U.S. Beef Market.

“Thanks for the excellent report and the insights regarding the lactose market.”

- Brazil based company specializing in production of protein ingredients.

“I liked the report; would it be possible to send me the PPT version as I want to use a few slides in an internal presentation that I am preparing.”

- Global Digital Services Agency on a report on the Global Luxury Goods Market.

“This report is really well done and we really appreciate it! Again, I may have questions as we dig in deeper. Thanks again for some really good work.”

- U.S.-based biotechnology company focussing on treatment of chronic pain.

“Kudos to your team. Thank you very much for your support and agility to answer our questions.”

- Europe-based provider of solutions to automate data centre operations.

“We appreciate you and your team taking out time to share the report and data file with us, and we are grateful for the flexibility provided to modify the document as per request. This does help us in our business decision making. We would be pleased to work with you again, and hope to continue our business relationship long into the future.”

- India-based manufacturer of industrial and specialty intermediates with a strong global presence.

“I want to first congratulate you on the great work done on the Medical Platforms project. Thank you so much for all your efforts.”

- One of the largest cosmetics company in the world.

“Thank you very much. I really appreciate the work your team has done. I feel very comfortable recommending your services to some of the other startups that I’m working with, and will likely establish a good long partnership with you.”

- U.S. based startup operating in the cultivated meat market.

“We received the below report on the U.S. market from you. We were very satisfied with the report.”

- Global hearing aids manufacturer.

“I just finished my first pass-through of the report. Great work! Thank you!”

- U.S. based solar racking solutions provider.

“Thanks again for the great work on our last partnership. We are ramping up a new project to understand the imaging and imaging service and distribution market in the U.S.”

- World’s leading advisory firm.

“We feel positive about the results. Based on the presented results, we will do strategic review of this new information and might commission a detailed study on some of the modules included in the report after end of the year. Overall we are very satisfied and please pass on the praise to the team. Thank you for the co-operation!”

- Germany based machine construction company.

“Thank you very much for the very good report. I have another requirement on cutting tools, paper crafts and decorative items.”

- Japanese manufacturing company of stationery products.

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X